NOOSPHERE

Public document records

Bibliographic records with public provenance and stable links. The catalog does not include all documents in the corpus or reproduce their full texts.

98,186 public records · page 196 / 982

  1. Neural mechanisms of psychedelic visual imagery2024 · Crossref
  2. Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin2024 · OpenAlex
  3. Neural responses to facial emotions and subsequent clinical outcomes in difficult-to-treat depression2024 · OpenAlex
  4. Neurexan Prescription Is Associated with Lower Risk of Sleep Disorder Recurrence and Depression Prevalence as Compared to Z-Drugs and Benzodiazepines: A Retrospective Database Analysis in Germany2024 · Crossref
  5. Neurite Orientation Dispersion and Density Imaging (NODDI) of Brain Microstructure in Adolescent Cannabis and Nicotine Use2024 · Crossref
  6. Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo2024 · OpenAlex
  7. Neuroanatomical, electrophysiological, and morphological characterization of melanin‐concentrating hormone cells coexpressing cocaine‐ and amphetamine‐regulated transcript2024 · Crossref
  8. Neurobiologie und Wirkmodelle zu Psychedelika2024 · OpenAlex
  9. Neurobiology, psychotherapeutic interventions, and emerging therapies in addiction: a systematic review2024 · OpenAlex
  10. Neurochemical characterization of 5-HT 2A R partial agonists with simultaneous PET-MRI2024 · OpenAlex
  11. Neurochemical mechanisms underlying serotonergic modulation of neuroplasticity in humans2024 · OpenAlex
  12. Neurocognitive function and medical care utilization in Veterans treated for substance use disorder2024 · Crossref
  13. Neurocognitive markers during maximum alcohol use in late adolescence as predictors of change in later drinking behaviors2024 · Crossref
  14. Neurodegenerative Diseases: from the First CNS Drugs to New Treatments in Discovery (A Review)2024 · OpenAlex
  15. Neurogenic Potential of Acacia oerfota: Evaluating the Effects of DMT-Rich Extract on PC12 Cells2024 · OpenAlex
  16. Neurogenic Pulmonary Edema Associated with Hyponatremia, Primary Polydipsia, and Cannabis Use: A Case Report2024 · Crossref
  17. Neuroimaging and the Investigation of Drug-Drug Interactions Involving Psychedelics2024 · Crossref
  18. Neuroimaging studies of cannabidiol and potential neurobiological mechanisms relevant for alcohol use disorders: a systematic review2024 · Crossref
  19. Neuroinflammation and major depressive disorder: astrocytes at the crossroads2024 · OpenAlex
  20. Neuroinflammatory history results in overlapping transcriptional signatures with heroin exposure in the nucleus accumbens and alters responsiveness to heroin in male rats2024 · Crossref
  21. Neuroleptic malignant syndrome and serotonin syndrome: a comparative bibliometric analysis2024 · OpenAlex
  22. Neurological Disorders Induced by Drug Use: Effects of Adolescent and Embryonic Drug Exposure on Behavioral Neurodevelopment2024 · Crossref
  23. Neuromodulation and mindfulness as therapeutic treatment in detoxified patients with alcohol use disorder2024 · Crossref
  24. Neuromodulation for Cannabis Use: A Scoping Review2024 · Crossref
  25. Neuropathic pain has sex‐specific effects on oxycodone‐seeking and non‐drug‐seeking ensemble neurons in the dorsomedial prefrontal cortex of mice2024 · Crossref
  26. Neuropathic pain, antidepressant drugs, and inflammation: a narrative review2024 · OpenAlex
  27. Neuropharmacological Advances: Harnessing 5-HT2A Receptor Modulators and Psychoplastogens2024 · OpenAlex
  28. Neuroplasticity and Cocaine Exposure During Adolescence2024 · Crossref
  29. Neuroplasticity and Mechanisms of Action of Acute and Chronic Treatment with Antidepressants in Preclinical Studies2024 · OpenAlex
  30. Neuroprotective Effect of a Pharmaceutical Extract of Cannabis with High Content on CBD Against Rotenone in Primary Cerebellar Granule Cell Cultures and the Relevance of Formulations2024 · Crossref
  31. Neuroprotective Effect of Red Betel (Piper crocatum) Extract on Brain Monosodium Gluatame (MSG)-Induced Rat (Rattus norvegicus)2024 · Crossref
  32. Neuroprotective effects of dantrolene in neurodegenerative disease: Role of inhibition of pathological inflammation2024 · OpenAlex
  33. Neuroprotective effects of psilocybin in a rat model of stroke2024 · OpenAlex
  34. NEUROPSYCHOLOGICAL MECHANISMS OF THE INFLUENCE OF SHAMANIC PRACTICES ON CREATIVITY: A MIXEDMETHODS STUDY2024 · OpenAlex
  35. Neuropsychological parameters in male offenders with substance use disorders2024 · Crossref
  36. Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controls2024 · Crossref
  37. Neuropsychopharmacological Induction of (Lucid) Dreams: A Narrative Review2024 · OpenAlex
  38. New and emerging treatments for major depressive disorder2024 · OpenAlex
  39. New Choking Epidemic Trends in Psychoactive Drugs: The Zombifying Combination of Fentanyl and Xylazine Cause Overdoses and Little Hope in Rehabilitation2024 · OpenAlex
  40. New concept: Treatment‐refractory addiction2024 · Crossref
  41. New drugs in the treatment of dual psychosis: use of cariprazine in schizophrenia, other psychotic disorders and use of cocaine. A case series in a specific outpatient psychiatric clinic for substance use disorders.2024 · Crossref
  42. New frontiers in the biosynthesis of psychoactive specialized metabolites2024 · OpenAlex
  43. New insight in psychotic cannabis withdrawal: case series and brief overview2024 · OpenAlex
  44. New insights in tobacco radiotoxicity: on the research of 210Po in modern heated tobacco product—radioactivity, distribution, and dose assessment2024 · Crossref
  45. New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity2024 · OpenAlex
  46. New pharmacotherapies to tackle the unmet needs in bipolar disorder: a focus on acute suicidality2024 · OpenAlex
  47. New Psychoactive Substances Toxicity: A Systematic Review of Acute and Chronic Psychiatric Effects2024 · Crossref
  48. NEW PSYCHOACTIVE SUBSTANCES – SOCIAL AND MEDICAL THREAT FOR THE STATE ASSOCIATED WITH THEM2024 · Crossref
  49. New Psychometric Strategies for the Evaluation of Affective, Cognitive, and Psychosocial Functioning in Unipolar versus Bipolar Depression: Impact of Drug Treatment2024 · Crossref
  50. New Territory: Ethical Challenges Associated With MDMA-Assisted Psychotherapy for PTSD2024 · OpenAlex
  51. New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances2024 · OpenAlex
  52. New York outlines job opportunities in the cannabis industry2024 · Crossref
  53. Next generation microsampling towards sustainable forensic analysis: Volumetric DBS for cocaine and metabolites2024 · OpenAlex
  54. Next Generation Peak Fitting for Separations2024 · Crossref
  55. Next‐generation biomarkers for alcohol consumption and alcohol use disorder diagnosis, prognosis, and treatment: A critical review2024 · Crossref
  56. NIAAA launches new website for teens on drinking2024 · Crossref
  57. NIAAA on harm reduction and contingency management2024 · Crossref
  58. NIAAA: Craving reduction and alcohol—a measure of recovery?2024 · Crossref
  59. Nickel and chromium ions release from stainless steel orthodontic bracket immersed in green betel leaf extract: an in vitro study2024 · Crossref
  60. Nicolas Garel: Combining psychoactive molecules and psychotherapy for patients suffering from mood and substance use disorders: a new therapeutic paradigm2024 · Crossref
  61. Nicotine, Humectants, and Tobacco-Specific Nitrosamines (TSNAs) in IQOS Heated Tobacco Products (HTPs): A Cross-Country Study2024 · Crossref
  62. NIDA on dramatic increase of mushroom seizures2024 · Crossref
  63. NIDA: More than 11% of high school seniors use delta‐82024 · Crossref
  64. NIDA: Psilocybin mushroom seizures rose significantly2024 · Crossref
  65. Nitazene test strips: a laboratory evaluation2024 · OpenAlex
  66. Nitazenes—heralding a second wave for the UK drug-related death crisis?2024 · OpenAlex
  67. Nitrogen application and cultivar effects on industrial hemp yield dynamics2024 · Crossref
  68. Niuhuang Qingxin Wan ameliorates depressive-like behaviors and improves hippocampal neurogenesis through modulating TrkB/ERK/CREB signaling pathway in chronic restraint stress or corticosterone challenge mice2024 · OpenAlex
  69. Nixi pae and its transcendental connection: An ethnographic essay on ayahuasca rituals in a Huni Kuin community in Brazil2024 · OpenAlex
  70. NMR-based approach to detect white wine vinegar fraud2024 · OpenAlex
  71. No Attainment, Nothing to Attain: A Buddhist Reflection on Psychedelics2024 · OpenAlex
  72. No free love: the dearth of media output from the Architectural Centre in the swinging sixties2024 · OpenAlex
  73. No-ciudad2024 · Crossref
  74. Nomophobia in India: A Psychological Disorder that Causes the Brain to Release Dopamine in Response to Tweets, Emoticons, and other Acts, Rewarding the Behaviour and Sustaining the Habit of using Social Media Addiction2024 · OpenAlex
  75. Nomophobia in India: A Psychological Disorder that Causes the Brain to Release Dopamine in Response to Tweets, Emoticons, and other Acts, Rewarding the Behaviour and Sustaining the Habit of Using Social Media Addiction2024 · OpenAlex
  76. Non-fatal drug overdose surveillance using hospital discharge data: a comparison between the Drug Overdose Surveillance and Epidemiology (DOSE) system and the Healthcare Cost and Utilisation Project, 18 states, 2018–20202024 · Crossref
  77. Non-hallucinogenic compounds derived from iboga alkaloids alleviate neuropathic and visceral pain in mice through a mechanism involving 5-HT2A receptor activation2024 · OpenAlex
  78. Non-hallucinogenic psychedelic psychotherapy: Decreasing risk and increasing access, or missing the point?2024 · Crossref
  79. Non-improvement predicts subsequent non-response to repeated-dose intravenous ketamine for depression: a re-analysis of a 2-week open-label study in patients with unipolar and bipolar depression2024 · OpenAlex
  80. Non-Intoxicating Cannabinoids in Visceral Pain2024 · Crossref
  81. Non-Invasive Detection of Nitrogen Deficiency in Cannabis sativa Using Hand-Held Raman Spectroscopy2024 · Crossref
  82. Non-linear plasma protein binding of cannabidiol2024 · Crossref
  83. Nonmedical cannabis legalization policy in Canada: Has commercialization been a pivotal mistake for public health?2024 · Crossref
  84. Nonmedical Use of Controlled Medications by Adolescents and Young Adults: Clinical Report2024 · Crossref
  85. Nonpharmacological pain management approaches among U.S. construction workers: A cross‐sectional pilot study2024 · OpenAlex
  86. Non‐alcoholic beverage consumption among US adults who consume alcohol2024 · Crossref
  87. North Carolina Medicaid System Perspectives on Substance Use Disorder Treatment Policy Changes During the COVID-19 Pandemic2024 · Crossref
  88. Not Carfentanil—A Case of Unexpected Xylazine Detection2024 · OpenAlex
  89. Notes from the Field: Schedule I Substances Identified in Nootropic Gummies Containing Amanita muscaria or Other Mushrooms — Charlottesville, Virginia, 2023–20242024 · OpenAlex
  90. Notes from the Field: Seizures, Hyperthermia, and Myocardial Injury in Three Young Adults Who Consumed Bromazolam Disguised as Alprazolam — Chicago, Illinois, February 20232024 · OpenAlex
  91. Noticing health warning labels and intentions to quit smokeless tobacco products: results from two Global Adult Tobacco Survey rounds, India2024 · Crossref
  92. Noticing Voluntary E-Cigarette Warning Labels and Associations With Harm Perceptions and Use Intentions: A Baseline Cross-Sectional Analysis of Wave 4 of the Population Assessment of Tobacco and Health Study Prior to the Food and Drug Administration Mandate2024 · Crossref
  93. Novel extended-release transdermal formulations of the psychedelic N,N-dimethyltryptamine (DMT)2024 · OpenAlex
  94. Novel harm reduction measures at music festivals in Australia: Pilot implementation of the Emerging Drugs Network of Australia–Victoria toxicosurveillance methodology2024 · OpenAlex
  95. Novel medications for problematic alcohol use2024 · OpenAlex
  96. Novel mimetic tissue standards for precise quantitative mass spectrometry imaging of drug and neurotransmitter concentrations in rat brain tissues2024 · Crossref
  97. Novel Pharmacologic and Other Somatic Treatment Approaches for Posttraumatic Stress Disorder in Adults: State of the Evidence2024 · OpenAlex
  98. Novel psychoactive substances (NPS): Update, issues and challenges2024 · OpenAlex
  99. Novel rapid treatment options for adolescent depression2024 · OpenAlex
  100. Novel rat model of gaming disorder: assessment of social reward and sex differences in behavior and c-Fos brain activity2024 · Crossref